PAPER Trojan E, Frydrych J, Lasoń W, Basta-Kaim A
SEARCH RESULTS
18390 RESULTS
PAPER Imhoff D, Sturzenegger R, Went P, Pantazis G
[Two Different Courses of a Rare, Potentially Reversible Encephalopathy].
Praxis (Bern 1994). 2025 Feb;114(2):66-71. PubMed.PAPER Reyes-Pablo AE, Luna-Viramontes NI, Montiel-Sosa JF, Ontiveros-Torres MÁ, Garcés-Ramírez L, de la Cruz-López F, Apátiga-Pérez R, Villanueva-Fierro I, Hernandes-Alejandro M, Jaramillo-Loranca BE, Vargas-Hernández G, Pacheco-Herrero M, Luna-Muñoz J
Vulnerability of the entorhinal cortex II to neurodegeneration in Alzheimer's disease.
Brain Commun. 2025;7(2):fcaf091. Epub 2025 Feb 26 PubMed.PAPER Abbott V, Housden BE, Houldsworth A
Could immunotherapy and regulatory T cells be used therapeutically to slow the progression of Alzheimer's disease?
Brain Commun. 2025;7(2):fcaf092. Epub 2025 Feb 25 PubMed.PAPER Ricci C
Neurodegenerative Disease: From Molecular Basis to Therapy, 2nd Edition.
Int J Mol Sci. 2025 Feb 24;26(5) PubMed.PAPER Silva J, Tumurbaatar B, Guptarak J, Zhang WR, Fracassi A, Taglialatela G
Sub-Immunosuppressive Tacrolimus Ameliorates Amyloid-Beta and Tau Pathology in 3xTg-AD Mice.
Int J Mol Sci. 2025 Feb 20;26(5) PubMed.PAPER Sheth U, Öijerstedt L, Heckman MG, White LJ, Heuer HW, Lario Lago A, Forsberg LK, Faber KM, Foroud TM, Rademakers R, Ramos EM, Appleby BS, Bozoki AC, Darby RR, Dickerson BC, Domoto-Reilly K, Galasko DR, Ghoshal N, Graff-Radford NR, Grant IM, Hales CM, Hsiung GR, Huey ED, Irwin D, Kwan JY, Litvan I, Mackenzie IR, Masdeu JC, Mendez MF, Onyike CU, Pascual B, Pressman PS, Roberson ED, Snyder A, Tartaglia MC, Seeley WW, Dickson DW, Rosen HJ, Boeve BF, Boxer AL, Petrucelli L, Gendron TF
Comprehensive cross-sectional and longitudinal comparisons of plasma glial fibrillary acidic protein and neurofilament light across FTD spectrum disorders.
Mol Neurodegener. 2025 Mar 12;20(1):30. PubMed.PAPER Grimaldi L, Cavallaro RA, De Angelis D, Fuso A, Sancesario G
Vitamin K Properties in Stroke and Alzheimer's Disease: A Janus Bifrons in Protection and Prevention.
Molecules. 2025 Feb 24;30(5) PubMed.PAPER Nakaya M, Kamagata K, Takabayashi K, Andica C, Uchida W, Hagiwara A, Akashi T, Wada A, Taoka T, Naganawa S, Abe O, Aoki S
Magnetic resonance imaging indices for early Alzheimer's disease detection: Brain clearance markers.
J Cereb Blood Flow Metab. 2025 Mar 13;:271678X251321305. Epub 2025 Mar 13 PubMed.PAPER Pang S, Li Z, Liu A, Luo ZH, Yin H, Fan S, Shi J, Liu N, Pan S, Yang YJ, Zhang GJ, Chen J
A Novel Oxo-Palmatine Derivative 2q as Potent Reversal Agents Against Alzheimer's Disease.
Drug Dev Res. 2025 Apr;86(2):e70073. PubMed.PAPER Salemme S, Lombardo FL, Lacorte E, Sciancalepore F, Remoli G, Bacigalupo I, Piscopo P, Zamboni G, Rossini PM, Cappa SF, Perani D, Spadin P, Tagliavini F, Vanacore N, Ancidoni A
The prognosis of mild cognitive impairment: A systematic review and meta-analysis.
Alzheimers Dement (Amst). 2025;17(1):e70074. Epub 2025 Mar 12 PubMed.PAPER Nie P, Wu Y, Robinson J, Mekala S, Lee VM, Li YM
In Situ Labeling of Pathogenic Tau Using Photo-Affinity Chemical Probes.
ACS Chem Biol. 2025 Mar 13; Epub 2025 Mar 13 PubMed.PAPER Gupta C, Kim C, Guzy S, Yoneyama T, Gharahi H, Siripuram VK, Iadevaia S, Barua D, Hang Y, Iakovleva T, Boucher C, Vakilynejad M, Schmidt S, Vozmediano V
Establishment of a Biomarker-Directed Clinical Endpoint Model for Early-Stage Parkinson's Disease Patients.
Clin Pharmacol Ther. 2025 Mar 12; Epub 2025 Mar 12 PubMed.PAPER Pérez-González AP, Anda-Jáuregui G, Hernández-Lemus E
Differential Transcriptional Programs Reveal Modular Network Rearrangements Associated with Late-Onset Alzheimer's Disease.
Int J Mol Sci. 2025 Mar 6;26(5) PubMed.PAPER Arnal Segura M, Bini G, Krithara A, Paliouras G, Tartaglia GG
Machine Learning Methods for Classifying Multiple Sclerosis and Alzheimer's Disease Using Genomic Data.
Int J Mol Sci. 2025 Feb 27;26(5) PubMed.Current Filters
- Date Range : Past 12 Months x